Charles Rice, PhD
Director
Dr. Rice is the Maurice R. and Corinne P. Greenberg Professor in Virology at Rockefeller and recipient of the Nobel Prize in Physiology or Medicine in 2020 for the discovery of the Hepatitis C virus, which affects over 60 million people worldwide and can result in liver cirrhosis and cancer. Dr. Rice’s lab studies pathogenic viruses and innate antiviral immune mechanisms.
Michel Nussenzweig, MD, PhD
Co-Director for Immunology
Dr. Nussenzweig is the Zanvil A. Cohen and Ralph M. Steinman Professor, Investigator Howard Hughes Medical Institute, Senior Physician at Rockefeller. His lab studies the molecular aspects of adaptive and innate immune responses which has led to the development of innovative vaccines against infectious diseases and new treatments for autoimmunity.
Barry Coller, MD
Co-Director for Clinical Studies
Dr. Coller is the David Rockefeller Professor, Physician-in-Chief, Vice President for Medical Affairs at the Rockefeller University Hospital. Current research in Dr. Coller’s lab focuses on multiple areas of platelet physiology. Among them is the genetic disorder Glanzmann thrombasthenia, which produces hemorrhage as a result of an abnormality of the platelet αIIbβ3 receptor.
Jill Horowitz, PhD
Program Director
Dr. Horowitz comes to the Institute with over 20 years of experience as a global project leader and business development and licensing director in the pharmaceutical industry and biotech CEO. The products developed under her leadership include vaccines and therapeutics against infectious diseases and cancer from lab bench to bedside in the developed and developing world.
